|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35,100.00 VND | -2.50% |
|
+0.29% | -33.14% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Manufacture Pharmaceutical Products and Trade Materials | 1,267B | 1,644B | 1,994B | 2,205B | 2,441B | |||||
Total Assets | 2,295B | 2,277B | 2,393B | 2,505B | 2,783B | |||||
Interest Expense | -5.5B | -3.79B | -6.04B | -3.49B | -16.5B | |||||
Income Tax Expense | 49.76B | 67.86B | 77.72B | 83.33B | 97.11B | |||||
CAPEX | -52.86B | -99.35B | -63.53B | -96.77B | -26.88B | |||||
EBT | 239B | 291B | 377B | 404B | 446B | |||||
Gross Profit | 488B | 697B | 811B | 856B | 1,002B | |||||
D&A | 59.72B | 60.23B | 81.99B | 104B | 103B | |||||
Operating Income | 234B | 291B | 374B | 403B | 445B | |||||
Net Income | 189B | 224B | 300B | 321B | 349B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Vietnam | - | 1,644B | 1,994B | 2,205B | 2,441B | |||||
Total Assets | - | 2,277B | 2,393B | 2,505B | 2,783B | |||||
Interest Expense | - | -3.79B | -6.04B | -3.49B | -16.5B | |||||
Income Tax Expense | - | 67.86B | 77.72B | 83.33B | 97.11B | |||||
D&A | - | 60.23B | 81.99B | 104B | 103B | |||||
CAPEX | - | -99.35B | -63.53B | -96.77B | -26.88B | |||||
Gross Profit | - | 697B | 811B | 856B | 1,002B | |||||
Net Income | - | 224B | 300B | 321B | 349B | |||||
EBT | - | 291B | 377B | 404B | 446B | |||||
Operating Income | - | 291B | 374B | 403B | 445B | |||||
Unallocated Discounts on Goods Sold | - | - | - | - | - | |||||
Unallocated Sales are Checked | - | - | - | - | - | |||||
Unallocated Commercial Discount | - | - | - | - | - | |||||
Export | - | - | - | - | - |
- Stock Market
- Stocks
- IMP Stock
- Financials Imexpharm Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
